Meticillin resistance in orthopaedic coagulase-negative staphylococcal infections

Journal of Hospital Infection

Volumn 79, Issue 3, 2011, Pages 248-253

  Uckay I ^a   Harbarth, S ^a   Ferry, T ^a   Lubbeke A ^a   Emonet, S ^a   Hoffmeyer, P ^a   Pittet, D ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Coagulase negative staphylococci; Implant associated infection; Meticillin resistance; Orthopaedic surgery; Secular trends

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFAZOLIN; CEFUROXIME; CIPROFLOXACIN; IMIPENEM; METICILLIN; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BONE INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ORTHOPEDIC PROSTHESIS; ORTHOPEDIC SURGERY; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION; TREND STUDY;

AGED; ANTI-BACTERIAL AGENTS; COAGULASE; COHORT STUDIES; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; MALE; METHICILLIN; METHICILLIN RESISTANCE; ORTHOPEDIC PROCEDURES; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; SWITZERLAND;

EID: 80053303648     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.06.014     Document Type: Article

References (32)

1. Kloos W.E., Bannerman T.L. Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 1994, 7:117-140.
2. Segawa H., Tsukayama D.T., Kyle R.F., Becker D.A., Gustilo R.B. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J Bone Joint Surg Am 1999, 81:1434-1445.
3. Fulkerson E., Valle C.J., Wise B., Walsh M., Preston C., Di Cesare P.E. Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. J Bone Joint Surg Am 2006, 88:1231-1237.
4. Uçkay I., Pittet D., Vaudaux P., Sax H., Lew D., Waldvogel F. Foreign body infections due to Staphylococcus epidermidis. Ann Med 2009, 41:109-119.
5. Adler H., Widmer A., Frei R. Emergence of a teicoplanin-resistant small colony variant of Staphylococcus epidermidis during vancomycin therapy. Eur J Clin Microbiol Infect Dis 2003, 22:746-748.
6. Mohanty S.S., Kay P.R. Infection in total joint replacements. Why we screen MRSA when MRSE is the problem?. J Bone Joint Surg Br 2004, 86:266-268.
7. James P.J., Butcher I.A., Gardner E.R., Hamblen D.L. Methicillin-resistant Staphylococcus epidermidis in infection of hip arthroplasties. J Bone Joint Surg Br 1994, 76:725-727.
8. Sanzen L., Walder M. Antibiotic resistance of coagulase-negative staphylococci in an orthopaedic department. J Hosp Infect 1988, 12:103-108.
9. Joshy S., Gogi N., Thomas B., Mahale A., Singh B.K. Delayed onset of deep infection after total knee arthroplasty: comparison based on the infecting organism. J Orthop Surg (Hong Kong) 2007, 15:154-158.
10. Thore M., Kuhn I., Lofdahl S., Burman L.G. Drug-resistant coagulase-negative skin staphylococci. Evaluation of four marker systems and epidemiology in an orthopaedic ward. Epidemiol Infect 1990, 105:95-105.
11. National Nosocomial Infections Surveillance (NNIS) System Report 2004. Am J Infect Control 2004, 32:470-485.
12. Widerstrom M., Monsen T., Karlsson C., Wistrom J. Molecular epidemiology of methicillin-resistant coagulase-negative staphylococci in a Swedish county hospital: evidence of intra- and interhospital clonal spread. J Hosp Infect 2006, 64:177-183.
13. Kitao T. Survey of methicillin-resistant coagulase-negative staphylococci isolated from the fingers of nursing students. J Infect Chemother 2003, 9:30-34.
14. Lübbeke A., Stern R., Garavaglia G., Zürcher L., Hoffmeyer P. Differences in outcomes of obese women and men undergoing primary total hip arthroplasty. Arthritis Rheum 2007, 57:327-334.
15. Yilmaz G., Aydin K., Iskender S., Caylan R., Köksal I. Detection and prevalence of inducible clindamycin resistance in staphylococci. J Med Microbiol 2007, 56:342-345.
16. Performance standards for antimicrobial susceptibility testing. 17th informational supplement (standard M100-S17) 2007, Clinical and Laboratory Standards Institute, CLSI, Wayne, PA.
17. Peduzzi P., Concato J., Feinstein A.R., Holford T.R. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995, 48:1503-1510.
18. Petignat C., Francioli P., Harbarth S., et al. Cefuroxime prophylaxis is effective in herniated disk surgery: a double-blind, placebo-controlled study. Spine 2008, 15:1919-1924.
19. Trampuz A., Zimmerli W. Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment. Drugs 2006, 66:1089-1105.
20. Hill C., Flamant R., Mazas F., Evrard J. Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial. Lancet 1981, 1:795-796.
21. Zingg W., Imhof A., Senn G., Demartines N., Ruef C. Rapid colonization with methicillin-resistant coagulase-negative staphylococci after surgery. World J Surg 2009, 33:2058-2062.
22. Lew D., Schrenzel J., Francois P., Vaudaux P. Pathogenesis, prevention, and therapy of staphylococcal prosthetic infections. Curr Clin Top Infect Dis 2001, 21:252-270.
23. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., Jarvis W.R. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999, 20:250-278.
24. Uçkay I., Vernaz-Hegi N., Harbarth S., et al. Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unit. J Infect 2009, 58:205-212.
25. Classen D.C., Evans R.S., Pestotnik S.L., Horn S.D., Menlove R.L., Burke J.P. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992, 326:281-286.
26. Mini E., Nobili S., Periti P. Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis?. Drugs 1997, 54:39-52.
27. Bolon M.K., Morlote M., Weber S.G., Koplan B., Carmeli Y., Wright S.B. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis 2004, 38:1357-1363.
28. Garey K.W., Lai D., Dao-Tran T.K., Gentry L.O., Hwang L.Y., Davis B.R. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery. Antimicrob Agents Chemother 2008, 52:446-451.
29. Cranny G., Elliott R., Weatherly H., et al. A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery. Health Technol Assess 2008, 12:1-168.
30. Berbari E.F., Marculescu C., Sia I., et al. Culture-negative prosthetic joint infection. Clin Infect Dis 2007, 45:1113-1119.
31. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions for nosocomial infections. Am J Infect Control 1988, 16:128-140.
32. Teterycz D., Ferry T., Lew D., et al. Outcome of orthopedic implant infections due to different staphylococci. Int J Infect Dis 2010, 14:913-918.